Douglas F. Kling - Jan 7, 2025 Form 4 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role
Chief Operating Officer
Signature
/s/ Louise Kooij by Power of Attorney from Douglas F. Kling
Stock symbol
NAMS
Transactions as of
Jan 7, 2025
Transactions value $
$0
Form type
4
Date filed
1/7/2025, 05:10 PM
Previous filing
Jan 6, 2025
Next filing
Jan 29, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAMS Ordinary Shares Award +44K 44K Jan 7, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date.
F2 Each RSU was granted on January 7, 2025 for no consideration.